Congestive heart failure is precisely what it sounds like; it is a failure of the heart to properly function, and its effects on the body can be devastating. Physicians do their best to treat the symptoms and give the patient the best prognosis possible; however, no true cure for congestive heart failure currently exists.
Heart failure occurs when the heart is unable to properly pump b…
Introduction
Hypertension (defined as a blood pressure 140/90 mmHg) is an extremely common comorbid condition in diabetes, affecting 2060% of patients with diabetes, depending on obesity, ethnicity, and age. In type 2 diabetes, hypertension is often present as part of the metabolic syndrome of insulin resistance …
For the first time since allopurinol [Zyloprim] was introduced in 1964, the medical management of chronic gout may soon include new treatment options. The xanthine oxidase inhibitor febuxostat is expected to be approved by the Food and Drug Administration some time this year. …
Tokyo, July 5, 2006 - (JCN) - Astellas Pharma and Nippon Boehringer Ingelheim have filed a joint application for an additional indication of Micardis, an angiotensin II receptor blocker, with the Ministry of Health, Labor and Welfare.
The two companies expect that Micardis will become applicable for the treatment of type 2 diabetic nephropathy. For this application, they have su…
Merck & Co’s angiotensin II receptor antagonist Cozaar (losartan) has become the first and only antihypertensive to be approved in the USA for reducing the risk of stroke in patients with high blood pressure and left ventricular hypertrophy, which can be a precursor to heart failure. However, new labeling for the product indicates that this …
Related Results
…
Interestingly, certain cases of high blood pressure are caused by a kidney problem. The kidneys play a large role in determining what our blood pressure is. The kidneys have a complex system of hormones that affect blood pressure under certain circumstances.
The primary kidney problem that leads to high bl…
DUBLIN, Ireland — Research and Markets (http://www.researchandmarkets.com/research/490602/cardiology_acute) has announced the addition of the “Cardiology - Acute Coronary Syndrome, Anticoagulants” report to their offering.
This repor…
DUBLIN, Ireland — Research and Markets (http://www.researchandmarkets.com/research/ce5f70/thought_leader_ins) has announced the addition of the “Thought Leader Insight & Analysis: Non-Interventional Cardiology” report to their offering.
This report provides in-depth analysis of the market and pipeline from the perspective of global thought…
Clinical Question: Are angiotensin receptor blockers (ARBs) as good as angiotensin-converting enzyme (ACE) inhibitors at preventing the progression of nephropathy?
Setting: Outpatient (any)
Study Design: Randomized controlled trial (double-blinded)
Allocation: Uncertain
Synopsis: In this study, 250 participants with diabetes who had mild to moderate hypertension and evidence of early nephropathy (i.e., urinary albumin excretion rate between 11 and 999 mcg…
Drug-induced pancreatitis is estimated to be responsible for nearly 2% of cases of acute pancreatitis. (1) Angiotensin-converting enzyme (ACE) inhibitors are some of the most widely prescribed medications. The occurrence of acute pancreatitis with several differen…
